Urology News and Research

Latest Urology News and Research

Experts to present diverse advances in neuromodulation at INS congress

Experts will present diverse advances in neuromodulation from May 27 to June 1, 2017 at the 13th World Congress of the International Neuromodulation Society in Edinburgh, Scotland.

30 Mar 2017

Study uncovers trigger for recurrent UTI infections

About half of all women will experience urinary tract infections in their lifetimes, and despite treatment, about a quarter will develop recurrent infections within six months of initial infection.

30 Mar 2017

Study explores new immunotherapy combinations to treat prostate cancer

Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.

29 Mar 2017

Survey finds alarming rates of shared decision making for prostate cancer screening

A new study finds that while a blood test that helps to screen for prostate cancer remains common, only 30 percent of men in a large national survey reported having a balanced discussion of the advantages and disadvantages of the screening with their doctor.

28 Mar 2017

Pelvic prolapse surgery using mesh no more effective than standard repair?

Women who have surgery for their prolapse have a 3 in 10 chance of needing at least one more operation, so the success rate is not great. Gynecologists hoped that using non-absorbable synthetic mesh or biological graft material as a patch to reinforce their standard repairs, the success rate would get better.

27 Mar 2017

New genetic test may give men better view on how to deal with prostate cancer risk

Scientists are reporting a test which can predict which patients are most at risk from aggressive prostate cancer, and whether they suffer an increased chance of treatment failure.

27 Mar 2017

Researchers study risk of thrombosis and bleeding in urological surgery

The international CLUE Working Group studied the risk of thrombosis and severe haemorrhage after urological cancer operations and other forms of urological surgery.

25 Mar 2017

Pioneering iPad case that protects medical practitioners, patients from HCAI risk may soon be available in Texas

A pioneering iPad case that enables clinical staff and surgeons to use iPads in sterile environments will soon be available in Texas.

22 Mar 2017

Nocturia is the top cause of sleep disturbance

‘On World Sleep Day sleep experts encourage people to understand the value of healthy and solid sleep. In particular, if they need to go to the toilet more than once in the night they have nocturia, a condition which affects one in three adults over the age of 30 and two thirds of adults over the age of 65.’

17 Mar 2017

York researchers move closer to finding new treatments for chronic bladder diseases

Using human cells, they have mapped how different proteins bind along the DNA to control which genes are active during barrier formation.

14 Mar 2017

Research project aims to develop wearable robotic system for keyhole surgery

A collaborative team of researchers is to develop a wearable robotic system for minimally invasive surgery, also known as keyhole surgery, that will offer surgeons natural and dexterous movement as well as the ability to 'sense', 'see', control and safely navigate through the surgical environment.

14 Mar 2017

Evolution of immuno-oncology

Immuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology department at GSK. He is also Senior Vice President Therapeutic Area (TA) and Head for Oncology R&D. Previously, it was referred to as cancer immunotherapy, but now it is called immuno-oncology (IO).

13 Mar 2017

Genentech grant funds home-based telemedicine program for treating MS patients

Multiple sclerosis (MS) clinicians face continued challenges in optimizing neurological care, especially for people with advanced MS living in medically underserved communities. Because of insurmountable geographical and physical challenges, patients cannot always travel to neurology office appointments.

10 Mar 2017

New biomarker 'Bim' could help predict optimal treatment for metastatic melanoma patients

Over the past few years, checkpoint blockade immunotherapies have revolutionized cancer treatment and helped many patients who were previously considered untreatable.

8 Mar 2017

Primary lung cancer tumor may go undiagnosed in some kidney cancer patients

Could lung cancer be hiding in kidney cancer patients? Researchers with the Harold C. Simmons Comprehensive Cancer Center's Kidney Cancer Program studied patients with metastatic kidney cancer to the lungs and found that 3.5 percent of the group had a primary lung cancer tumor that had gone undiagnosed. This distinction can affect treatment choices and rates of surviva

7 Mar 2017

New technique can effectively identify cancer-causing substances in urine or blood

A team of researchers, led by Professor Yoon-Kyoung Cho of Life Science at UNIST has recently developed a new technique that effectively identifies cancer-causing substances in the urine or blood.

7 Mar 2017

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

3 Mar 2017

Study provides insights into how cancer cells can evade FGFR inhibitors

A new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has identified a mechanism by which cancer cells develop resistance to a class of drugs called fibroblast growth factor receptor (FGFR) inhibitors.

2 Mar 2017

New test reveals the truth about how much urine is in swimming pools

Scientists have designed a new way of testing the amount of urine present in swimming pools, according to a Canadian study.

2 Mar 2017

$Study highlights potential tolerability of single fraction of HDR brachytherapy for localized prostate cancer$

Study highlights potential tolerability of single fraction of HDR brachytherapy for localized prostate cancer

Results from a new prospective clinical trial indicate that high-dose-rate (HDR) brachytherapy administered in a single, 19 Gray treatment may be a safe and effective alternative to longer courses of HDR treatment for men with localized prostate cancer.

1 Mar 2017